Seretide

Phase 3Peptide

Seretide is one of 81 small molecule programs targeting Chronic Obstructive Pulmonary Disease. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Chronic Obstructive Pulmonary DiseaseActive, not recruiting

Allergic AsthmaActive, not recruiting

AsthmaActive, not recruiting

Chronic Obstructive Pulmonary DiseasePhase 2

Active, not recruiting

Allergic AsthmaPhase 3

Active, not recruiting

AsthmaPhase 3

Active, not recruiting

Competition

Competitive Landscape

1050 competitors in Asthma

#DrugCompanyPhaseTrials

Seretide

GSK

Phase 3

8 2

Singulair

AstraZeneca

Preclinical

17 3

Nucala

GGlaxo Dba Glaxosmithkline

Preclinical

35 4

Cinqair

Teva

Preclinical

13 5

Spiriva

Boehringer Ingelheim

Preclinical

8 6

Qvar

Chiesi Farmaceutici S.p.A.

Preclinical

8 7

Blood Withdrawn

Emergent BioSolutions

Preclinical

1 8

Allergen Immunotherapy Extract

JJohns Hopkins University

Preclinical

1 9

Inhaled Corticosteroids

Boehringer Ingelheim

Preclinical

6 10

Guanidine Hydrochloride

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Asthma8 trials

Comparison of Anti-inflammatory Effects of Seroflo and Seretide in Patients With Asthma

Completed·MMahidol University·Phase 3·NCT01274325·51 enrolled

A Non- Inferiority Comparative Study Between Seretide® and Salmeterol/Fluticasone Eurofarma in Patients with Asthma

Completed·EEurofarma Laboratorios S.A.·Phase 3·NCT01202097·334 enrolled

Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients

Completed·MMundipharma Research Limited·Phase 3·NCT01511367·498 enrolled

Show 5 more trials

Real Life Effectiveness in Patients With Not Optimally Controlled Asthma

Completed·FFar Eastern Memorial Hospital·Phase 4·NCT01647646·200 enrolled

SERETIDE Vs FLIXOTIDE In Mild Persistent Asthma (GINAII)

Completed· GSK logo

GSK·Phase 4·NCT00455923·100 enrolled

Additive Effects of QVAR to (Seretide) on Surrogate Markers of Airway Inflammation in Refractory Asthma

Completed·UUniversity of Dundee·Phase 4·NCT00829257·15 enrolled

Salmeterol Xinafoate and Fluticasone Propinate Powder for Inhalation for Asthma

Unknown status· Chia Tai Tianqing Pharmaceutical Group Co., Ltd. logo

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.·Phase 3·NCT03461627·300 enrolled

Elite Sport and Development of Asthma

Completed·—·Phase 4·NCT00262587·18 enrolled

Chronic Obstructive Pulmonary Disease1 trial

A 12 Week Study To Assess Efficacy And Safety Of GW856553 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Completed· GSK logo

GSK·Phase 2·NCT00642148·306 enrolled

Treatment1 trial

FACTO Study (Foster® As Complete Treatment Option)

Completed· Chiesi Farmaceutici S.p.A. logo

Chiesi Farmaceutici S.p.A.·Phase 4·NCT00901368·431 enrolled

Allogeneic Hematopoietic Stem Cell Transplantation1 trial

Efficacy of Fluticasone Propionate Associated With Salmeterol Using Inhalation Chamber Versus Placebo to Improve the Respiratory Function in Children Over Six Years of Age Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation With a Decline of FEV1 ≥10% From Pre Transplantation

Terminated·AAssistance Publique - Hôpitaux de Paris·Phase 3·NCT04655508·35 enrolled

Allergic Asthma1 trial

Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.

Completed·SShanghai Biomabs Pharmaceutical Co., Ltd.·Phase 3·NCT03468790·393 enrolled

Sources

References

[1]
ClinicalTrials.gov — 12 trial records for Seretide. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Seretide compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Seretide. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — GSK company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Peptide[2]
Highest Phase: Phase 3[1]
Company: GSK

Seretide

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Asthma8 trials

Chronic Obstructive Pulmonary Disease1 trial

Treatment1 trial

Allogeneic Hematopoietic Stem Cell Transplantation1 trial

Allergic Asthma1 trial

References

Drug Info

Quick Facts

Related News